SCHEMBL1923317

SCHEMBL1923317

Oc1cc2c(cc1-c1nncn1-c1ccc(N3CCOCC3)cc1)OCO2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
P4HB P07237 5/20 0.41
SMAD3 P84022 4/20 0.41
MIF P14174 1/20 0.39
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
PRKDC P78527 2/20 0.38
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
MAP3K5 Q99683 2/20 0.37
FLT3 P36888 1/20 0.37
CDK1 P06493 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1923168 0.74 CYP11B2 (0.38) MAPTNPC1RAB9AALDH1A1PIK3CA
SCHEMBL1923039 0.74 MAPT (0.43) MAPTNPC1RAB9AGAAL3MBTL1
SCHEMBL14105031 0.69 HSP90AA1 (0.64) MAPTGAAALDH1A1
SCHEMBL19500868 0.68 MAPT (0.59) MAPTNPC1RAB9AGAAL3MBTL1
SCHEMBL12255510 0.65 MAPT (0.56) MAPTNPC1RAB9AGAAL3MBTL1
SCHEMBL24434308 0.64 CYP3A4 (0.56) MAPTNPC1RAB9AP4HBSMAD3
SCHEMBL1305116 0.63 BRD9 (0.44) MAPTNPC1RAB9AALDH1A1CYP3A4
SCHEMBL12128810 0.62 MAPT (0.62) MAPTNPC1RAB9AGAAL3MBTL1
SCHEMBL9093746 0.62 LMNA (0.71) MAPTNPC1RAB9AALDH1A1CYP1A2
SCHEMBL11791151 0.62 PRKDC (0.65) MAPTNPC1RAB9AALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2328893-A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY Synta Pharmaceuticals Corp. (US) 2011-06-08 EP claimed
WO-2010017479-A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP. (US) 2010-02-11 WO claimed